ImmPACT Bio USA, Inc, a clinical-stage company, announced on Tuesday that it has named Jonathan Benjamin, MD, Ph.D. as its chief medical officer.
In the new role, Dr Benjamin is to head the company's clinical development strategy.
Dr Benjamin has served as senior vice president for clinical research at Atreca, Inc and medical director at Amgen Inc. He has also served as an assistant professor of medicine in the Division of Blood and Marrow Transplant at Stanford University School of Medicine.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer